132 related articles for article (PubMed ID: 6644883)
1. The treatment of renal cell carcinoma with human leukocyte alpha-interferon.
deKernion JB; Sarna G; Figlin R; Lindner A; Smith RB
J Urol; 1983 Dec; 130(6):1063-6. PubMed ID: 6644883
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma.
Kinney P; Triozzi P; Young D; Drago J; Behrens B; Wise H; Rinehart JJ
J Clin Oncol; 1990 May; 8(5):881-5. PubMed ID: 2332772
[TBL] [Abstract][Full Text] [Related]
3. Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.
Sarna G; Figlin R; Callaghan M
J Biol Response Mod; 1983; 2(4):343-7. PubMed ID: 6315898
[TBL] [Abstract][Full Text] [Related]
4. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon].
Kawamura J; Yamauchi T; Hashimura T; Yoshida O; Kohnami T; Tomoyoshi T; Ogura K; Fukuyama T; Nakagawa K
Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum.
Figlin RA; Callaghan M; Sarna G
Cancer Treat Rep; 1983 May; 67(5):493-4. PubMed ID: 6850664
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials.
Ryan CW; Vogelzang NJ; Dumas MC; Kuzel T; Stadler WM
Cancer; 2000 Mar; 88(6):1317-24. PubMed ID: 10717612
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
Vugrin D; Hood L; Taylor W; Laszlo J
Cancer Treat Rep; 1985; 69(7-8):817-20. PubMed ID: 4016792
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma.
Grunberg SM; Kempf RA; Itri LM; Venturi CL; Boswell WD; Mitchell MS
Cancer Treat Rep; 1985 Sep; 69(9):1031-2. PubMed ID: 4028036
[No Abstract] [Full Text] [Related]
9. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.
Chaplinski T; Laszlo J; Moore J; Silverman P
Cancer Treat Rep; 1983 Nov; 67(11):1009-12. PubMed ID: 6640552
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials.
Umeda T; Niijima T
Cancer; 1986 Sep; 58(6):1231-5. PubMed ID: 3742449
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma: antitumor effects of leukocyte interferon.
Quesada JR; Swanson DA; Trindade A; Gutterman JU
Cancer Res; 1983 Feb; 43(2):940-7. PubMed ID: 6336662
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report.
Quesada JR; Swanson DA; Gutterman JU
J Clin Oncol; 1985 Aug; 3(8):1086-92. PubMed ID: 4020410
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial.
Krown SE; Burk MW; Kirkwood JM; Kerr D; Morton DL; Oettgen HF
Cancer Treat Rep; 1984 May; 68(5):723-6. PubMed ID: 6722830
[TBL] [Abstract][Full Text] [Related]
14. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
Figlin RA; deKernion JB; Maldazys J; Sarna G
Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
[TBL] [Abstract][Full Text] [Related]
15. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
Furue H
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia.
Foon KA; Bottino GC; Abrams PG; Fer MF; Longo DL; Schoenberger CS; Oldham RK
Am J Med; 1985 Feb; 78(2):216-20. PubMed ID: 3970047
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinoma.
Schornagel JH; Verweij J; ten Bokkel Huinink WW; Klijn JG; de Mulder PH; Debruyne FM; van Deijk WA; Roozendaal K; Kok TC; Veenhof KH
J Urol; 1989 Aug; 142(2 Pt 1):253-6. PubMed ID: 2746739
[TBL] [Abstract][Full Text] [Related]
18. Angioinfarction plus nephrectomy for metastatic renal cell carcinoma--an update.
Swanson DA; Johnson DE; von Eschenbach AC; Chuang VP; Wallace S
J Urol; 1983 Sep; 130(3):449-52. PubMed ID: 6887354
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte interferon as part of a combined treatment for previously untreated small cell lung cancer.
Mattson K; Holsti LR; Niiranen A; Kivisaari L; Iivanainen M; Sovijärvi A; Cantell K
J Biol Response Mod; 1985 Feb; 4(1):8-17. PubMed ID: 2984340
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
Kirkwood JM; Harris JE; Vera R; Sandler S; Fischer DS; Khandekar J; Ernstoff MS; Gordon L; Lutes R; Bonomi P
Cancer Res; 1985 Feb; 45(2):863-71. PubMed ID: 3881175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
